SCHEMBL21325267

SCHEMBL21325267

CN1CCC(COc2cc(C(C)(C)C)ccc2F)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DUT P33316 3/20 0.44
▸ EGFR P00533 6/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ KDR P35968 5/20 0.41
▸ FGFR1 P11362 4/20 0.41
▸ FLT1 P17948 4/20 0.41
▸ FLT4 P35916 4/20 0.41
▸ RET P07949 4/20 0.40
▸ KIF5B P33176 2/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ BMPR1B O00238 1/20 0.40
▸ PLK4 O00444 1/20 0.40
▸ CIT O14578 1/20 0.40
▸ GAK O14976 1/20 0.40
▸ EPHB6 O15197 1/20 0.40
▸ RIPK2 O43353 1/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ STK10 O94804 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20347946 0.89 DUT (0.46) DUTHTR2AHTR2BGRM2
SCHEMBL23052811 0.89 DUT (0.42) DUTEGFRKDRFGFR1FLT1
SCHEMBL21325069 0.86 DUT (0.41) DUTALDH1A1ALOX15HSD17B10CNR2
SCHEMBL20202148 0.86 GRM2 (0.43) DUTHTR2AHTR2BGRM2
SCHEMBL20347951 0.86 DUT (0.42) DUTSLC6A4GRM2
SCHEMBL21325270 0.83 EP300 (0.49) DUTEGFRKDRFGFR1FLT1
SCHEMBL21325101 0.83 GRM2 (0.44) DUTALDH1A1CNR2HTR2AHTR2B
SCHEMBL20207512 0.80 CNR2 (0.38) DUTALDH1A1HSD17B10CNR2HTT
SCHEMBL21325081 0.80 DUT (0.40) DUTSLC6A4HTR2B
SCHEMBL21324916 0.80 CHRNB4 (0.52) CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518746-B2 Nitrogen ring linked deoxyuridine triphosphatase inhibitors CV6 THERAPEUTICS (NI) LIMITED (GB) 2022-12-06 — — US disclosed
US-11247984-B2 Uracil containing compounds CV6 THERAPEUTICS (NI) LIMITED (GB) 2022-02-15 — — US disclosed
US-11174271-B2 6-membered uracil isosteres CV6 THERAPEUTICS (NI) LIMITED (GB) 2021-11-16 — — US disclosed
US-11168059-B2 Amino sulfonyl compounds CV6 THERAPEUTICS (NI) LIMITED (GB) 2021-11-09 — — US disclosed
US-11014924-B2 Hydantoin containing deoxyuridine triphosphatase inhibitors CV6 THERAPEUTICS (NI) LIMITED (GB) 2021-05-25 — — US disclosed
US-20210061767-A1 NITROGEN RING LINKED DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CV6 THERAPEUTICS (NI) LIMITED (GB) 2021-03-04 — — US disclosed
US-10858344-B2 Hydantoin containing deoxyuridine triphosphatase inhibitors CV6 THERAPEUTICS (NI) LIMITED (GB) 2020-12-08 — — US disclosed
US-10829457-B2 Nitrogen ring linked deoxyuridine triphosphatase inhibitors CV6 THERAPEUTICS (NI) LIMITED (GB) 2020-11-10 — — US disclosed
US-20200039966-A1 URACIL CONTAINING COMPOUNDS CV6 THERAPEUTICS (NI) LIMITED (GB) 2020-02-06 — — US disclosed
US-20190330158-A1 AMINO SULFONYL COMPOUNDS CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-10-31 — — US disclosed
US-20190330210-A1 HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-10-31 — — US disclosed
US-20190276410-A1 NITROGEN RING LINKED DEOXYURIDINE TRIPHOSPHATASE INHIBITORS CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-09-12 — — US disclosed
US-20190270756-A1 6-MEMBERED URACIL ISOSTERES CV6 THERAPEUTICS (NI) LIMITED (GB) 2019-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174271-B2 6-membered uracil isosteres UNG, DUT, DPYD DUT 2/4885EGFR 3945/4885ALDH1A1 972/4885
US-20210061767-A1 NITROGEN RING LINKED DEOXYURIDINE TRIPHOSPHATASE INHIBITORS DUT, DPYD, TYMP DUT 1/4885EGFR 4098/4885ALDH1A1 1672/4885
US-20190330210-A1 HYDANTOIN CONTAINING DEOXYURIDINE TRIPHOSPHATASE INHIBITORS DUT, TYMP, DPYD DUT 1/4885EGFR 4736/4885ALDH1A1 1207/4885
US-10858344-B2 Hydantoin containing deoxyuridine triphosphatase inhibitors DUT, TYMP, DPYD DUT 1/4885EGFR 4736/4885ALDH1A1 1207/4885
US-11168059-B2 Amino sulfonyl compounds DPYD, DNPEP, DUT DUT 3/4885EGFR 3488/4885ALDH1A1 2924/4885
US-20190330158-A1 AMINO SULFONYL COMPOUNDS DPYD, DNPEP, DUT DUT 3/4885EGFR 3488/4885ALDH1A1 2924/4885
US-10829457-B2 Nitrogen ring linked deoxyuridine triphosphatase inhibitors DUT, DPYD, TYMP DUT 1/4885EGFR 4098/4885ALDH1A1 1672/4885
US-11014924-B2 Hydantoin containing deoxyuridine triphosphatase inhibitors DUT, TYMP, DPYD DUT 1/4885EGFR 4736/4885ALDH1A1 1207/4885
US-20200039966-A1 URACIL CONTAINING COMPOUNDS UNG, DPYD, DUT DUT 3/4885EGFR 4099/4885ALDH1A1 970/4885
US-11518746-B2 Nitrogen ring linked deoxyuridine triphosphatase inhibitors DUT, DPYD, TYMP DUT 1/4885EGFR 4098/4885ALDH1A1 1672/4885
US-11247984-B2 Uracil containing compounds UNG, DPYD, DUT DUT 3/4885EGFR 4099/4885ALDH1A1 970/4885
US-20190276410-A1 NITROGEN RING LINKED DEOXYURIDINE TRIPHOSPHATASE INHIBITORS DUT, DPYD, TYMP DUT 1/4885EGFR 4098/4885ALDH1A1 1672/4885
US-20190270756-A1 6-MEMBERED URACIL ISOSTERES UNG, DUT, DPYD DUT 2/4885EGFR 3945/4885ALDH1A1 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback